Test Code FXIII Factor XIII (13), Screen, Plasma
Reporting Name
Factor XIII(13),ScrnPerforming Laboratory
Mayo Clinic Laboratories in RochesterUseful For
Screening for factor XIII deficiency
Method Name
Only orderable as part of a profile. For more information see ALBLD / Bleeding Diathesis Profile, Limited, Plasma.
Clot-Based
Specimen Required
Only orderable as part of a profile. For more information see ALBLD / Bleeding Diathesis Profile, Limited, Plasma.
Specimen Type
Plasma Na CitSpecimen Stability Information
Specimen Type | Temperature | Time | Special Container |
---|---|---|---|
Plasma Na Cit | Frozen | 14 days |
Reject Due To
Gross hemolysis | Reject |
Gross lipemia | Reject |
Gross icterus | Reject |
Reference Values
Only orderable as part of a profile. For more information see ALBLD / Bleeding Diathesis Profile, Limited, Plasma.
Normal
Interpretation
Normally, no clot dissolution is observed after 30 minutes in 1% monochloroacetic acid. Clot dissolution begins once factor XIII levels are reduced to 1% or 2%.
Day(s) Performed
Monday through Friday
Report Available
1 to 4 daysTest Classification
This test was developed and its performance characteristics determined by Mayo Clinic in a manner consistent with CLIA requirements. It has not been cleared or approved by the US Food and Drug Administration.CPT Code Information
85291
LOINC Code Information
Test ID | Test Order Name | Order LOINC Value |
---|---|---|
FXIII | Factor XIII(13),Scrn | 3241-7 |
Result ID | Test Result Name | Result LOINC Value |
---|---|---|
9068 | Factor XIII(13),Scrn | 3241-7 |